Researchers from King’s College London and San Diego State University (SDSU) in California have ...

Neomorph begins human testing of a molecular glue therapy that selectively removes cancer-driving proteins, targeting clear cell renal cell carcinoma.

Congenital stationary night blindness (CSNB) is caused by mutations in a specific calcium channel. A comprehensive proteomic study by researchers at the University of Innsbruck now reveals how these ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of a ...

This local biotech says it has found a way to trick cancer cells into destroying themselves with its molecular glue. Now it’s putting that claim to the test. After attracting global attention from ...

Physicists have watched a quantum fluid do something once thought almost impossible: stop moving. In experiments with ...

Through a combination of high-pressure experiments and optical spectroscopy, physicists have revealed new insights into the ...

Molecular study of spider silk shows how amino acids drive strength and elasticity, guiding synthetic fibre design.

Scientists have identified the molecular interactions that give spider silk its exceptional strength, opening the door to new ...

Specific tumor accumulation and attractive biodistribution highly supportive of MP0712 clinical development for treatment of DLL3-expressing ...

NEW YORK, NY / ACCESS Newswire / January 16, 2026 / The global gold market functions on faith. Vault operators rely on ...

A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to ...